Status:
UNKNOWN
The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
16+ years
Brief Summary
This study uses serum tissue factor and tissue factor inhibitor and factor VII to monitor the pre-coagulation status in lung cancer patients and to correlate the pre-coagulation status with clinical s...
Detailed Description
The staging of lung cancer was according to tumor size, involvement of lymph node and metastatic status. But there is a different prognosis in cancer patients of the same stage. The coagulation status...
Eligibility Criteria
Inclusion
- Patients with newly-diagnosed lung cancer
- Serum from cancer-free healthy volunteers
Exclusion
- Chronic renal failure or end-stage renal disease \[ESRD\] (creatinine \[Cr\] \> 2 )
- Hyperlipidemia on statin therapy
- Acute myocardial infarction
- Tapal or Plavix use
- Active thromboembolic event
- Severe liver disease (\> child B)
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00257179
Start Date
June 1 2005
Last Update
March 14 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan